Resolution of type 2 diabetes following gastric bypass surgery: Involvement of gut-derived glucagon and glucagonotropic signalling?

Diabetologia

Volumn 52, Issue 11, 2009, Pages 2270-2276

  Knop, F K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bariatric surgery; Biliopancreatic diversion; Glucagon; Glucagon like peptide 1; Glucagon like peptide 2; Glucose dependent insulinotropic polypeptide; Incretin hormones; Roux en Y gastric bypass; Type 2 diabetes

Indexed keywords

GASTROINTESTINAL HORMONE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN;

BARIATRIC SURGERY; DIABETOGENESIS; DISEASE PREDISPOSITION; GASTRIC BANDING; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HORMONE RELEASE; HUMAN; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; HYPOTHESIS; INSULIN BLOOD LEVEL; INSULIN SYNTHESIS; L CELL; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT SUPPLY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET ALPHA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMISSION; REVIEW; ROUX Y ANASTOMOSIS; SIGNAL TRANSDUCTION; SMALL INTESTINE; STOMACH BYPASS; WEIGHT REDUCTION;

DIABETES MELLITUS, TYPE 2; DIGESTION; GASTRIC BYPASS; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; HUMANS; INTESTINE, SMALL; JEJUNUM; MODELS, BIOLOGICAL; PROGLUCAGON; SIGNAL TRANSDUCTION;

EID: 70349847567     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1511-8     Document Type: Review

References (50)

1. WJ Pories MS Swanson KG MacDonald, et al. 1995 Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 222 339 350 7677463 10.1097/00000658-199509000-00011 1:STN:280:DyaK2Mvgsl2ltA%3D%3D
2. EE Mason 2005 The mechanisms of surgical treatment of type 2 diabetes Obes Surg 15 459 461 15946422 10.1381/0960892053723330 (Pubitemid 40605066)
3. F Rubino M Gagner 2002 Potential of surgery for curing type 2 diabetes mellitus Ann Surg 236 554 559 12409659 10.1097/00000658-200211000-00003 (Pubitemid 35246885)
4. HC Fehmann R Goke B Goke 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide Endocr Rev 16 390 410 7671853 1:CAS:528:DyaK2MXmslCqtbY%3D
5. Y Wang R Perfetti NH Greig, et al. 1997 Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats J Clin Invest 99 2883 2889 9185511 10.1172/JCI119482 1:CAS:528:DyaK2sXktV2qtbs%3D
6. J Buteau W El-Assaad CJ Rhodes L Rosenberg E Joly M Prentki 2004 Glucagon-like peptide-1 prevents beta cell glucolipotoxicity Diabetologia 47 806 815 15095038 10.1007/s00125-004-1379-6 1:CAS:528:DC%2BD2cXksFGitb4%3D (Pubitemid 38756992)
7. H Larsson JJ Holst B Ahren 1997 Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans Acta Physiol Scand 160 413 422 9338524 10.1046/j.1365-201X.1997.00161.x 1:CAS:528:DyaK2sXlsVGmsLc%3D
8. JJ Holst 2007 The physiology of glucagon-like peptide 1 Physiol Rev 87 1409 1439 17928588 10.1152/physrev.00034.2006 1:CAS:528:DC%2BD2sXhtlaqu7jI (Pubitemid 350041474)
9. CM Borg CW Le Roux MA Ghatei SR Bloom AG Patel SJ Aylwin 2006 Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety Br J Surg 93 210 215 16392104 10.1002/bjs.5227 1:CAS:528:DC%2BD28XisF2gsrs%3D (Pubitemid 43259607)
10. B Laferrere S Heshka K Wang, et al. 2007 Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 1709 1716 17416796 10.2337/dc06-1549 1:CAS:528:DC%2BD2sXotlWhsbw%3D (Pubitemid 47036341)
11. CW Le Roux SJ Aylwin RL Batterham, et al. 2006 Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters Ann Surg 243 108 114 16371744 10.1097/01.sla.0000183349.16877.84 (Pubitemid 43054062)
12. E Naslund P Gryback PM Hellstrom, et al. 1997 Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity Int J Obes Relat Metab Disord 21 387 392 9152741 10.1038/sj.ijo.0800418 1:STN:280:DyaK2s3pslaksA%3D%3D
13. MS Hickey WJ Pories KG MacDonald Jr, et al. 1998 A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 227 637 643 9605655 10.1097/00000658-199805000-00004 1:STN:280:DyaK1c3ms1KqsA%3D%3D (Pubitemid 28530913)
14. WJ Pories RJ Albrecht 2001 Etiology of type II diabetes mellitus: role of the foregut World J Surg 25 527 531 11344408 10.1007/s002680020348 1:STN:280:DC%2BD3M3kt1eqtA%3D%3D (Pubitemid 32455209)
15. F Rubino A Forgione DE Cummings, et al. 2006 The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes Ann Surg 244 741 749 17060767 10.1097/01.sla.0000224726.61448.1b (Pubitemid 44629948)
16. F Rubino J Marescaux 2004 Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease Ann Surg 239 1 11 14685093 10.1097/01.sla.0000102989.54824.fc (Pubitemid 38176365)
17. RH Unger L Orci 1981 Glucagon and the A cell: physiology and pathophysiology (second of two parts) N Engl J Med 304 1575 1580 7015135 1:CAS:528:DyaL3MXksVSgsrY%3D (Pubitemid 11122505)
18. P Shah A Vella A Basu R Basu WF Schwenk RA Rizza 2000 Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus J Clin Endocrinol Metab 85 4053 4059 11095432 10.1210/jc.85.11.4053 1:CAS:528:DC%2BD3cXotlWntbw%3D (Pubitemid 32055352)
19. RD Kirk P Dunn JR Smith DW Beaven RA Donald 1975 Abnormal pancreatic alpha-cell function in first-degree relatives of known diabetics J Clin Endocrinol Metab 40 913 916 1092713 10.1210/jcem-40-5-913 1:STN:280: DyaE2M7ltF2hsw%3D%3D
20. FK Knop T Vilsboll S Madsbad JJ Holst T Krarup 2007 Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus Diabetologia 50 797 805 17225124 10.1007/s00125-006-0566-z 1:CAS:528: DC%2BD2sXitlOntrw%3D (Pubitemid 46355821)
21. FK Knop T Vilsboll PV Hojberg, et al. 2007 Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 56 1951 1959 17513701 10.2337/db07-0100 1:CAS:528:DC%2BD2sXos12qsro%3D (Pubitemid 47195814)
22. E Muscelli A Mari A Casolaro, et al. 2008 Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients Diabetes 57 1340 1348 18162504 10.2337/db07-1315 1:CAS:528: DC%2BD1cXlvVKjtb0%3D
23. JJ Meier CF Deacon WE Schmidt JJ Holst MA Nauck 2007 Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects Diabetologia 50 806 813 17334652 10.1007/s00125-007-0598-z 1:CAS:528:DC%2BD2sXitlOnur8%3D (Pubitemid 46355834)
24. JJ Holst 1978 Extra-pancreatic glucagons Digestion 17 168 190 342323 10.1159/000198107 1:CAS:528:DyaE1cXntFyktg%3D%3D
25. JJ Holst JH Pedersen F Baldissera F Stadil 1983 Circulating glucagon after total pancreatectomy in man Diabetologia 25 396 399 6653943 10.1007/BF00282517 1:CAS:528:DyaL2cXmt1anuw%3D%3D
26. FGA Baldissera JJ Holst 1984 Glucagon-related peptides in the human gastrointestinal mucosa Diabetologia 26 223 228 6546922 10.1007/BF00252412 1:CAS:528:DyaL2cXktVWhtLY%3D
27. S Dhanvantari NG Seidah PL Brubaker 1996 Role of prohormone convertases in the tissue-specific processing of proglucagon Mol Endocrinol 10 342 355 8721980 10.1210/me.10.4.342 1:CAS:528:DyaK28XitFSlt7g%3D (Pubitemid 26112399)
28. GI Bell PR Sanchez PJ Laybourn RC Najarian 1983 Exon duplication and divergence in the human preproglucagon gene Nature 304 368 371 6877358 10.1038/304368a0 1:CAS:528:DyaL3sXlsFejur0%3D
29. R Eissele R Goke S Willemer, et al. 1992 Glucagon-like peptide-1 cells in the gastrointestinal-tract and pancreas of rat, pig and man Eur J Clin Invest 22 283 291 1499644 10.1111/j.1365-2362.1992.tb01464.x 1:CAS:528: DyaK38XktVWgu70%3D
30. MJ Theodorakis O Carlson S Michopoulos, et al. 2006 Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP Am J Physiol Endocrinol Metab 290 E550 E559 16219666 10.1152/ajpendo.00326.2004 1:CAS:528:DC%2BD28Xjt1SksL4%3D (Pubitemid 43671703)
31. RS Jackson JWM Creemers IS Farooqi, et al. 2003 Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency J Clin Invest 112 1550 1560 14617756 1:CAS:528:DC%2BD3sXptFWqtL0%3D
32. R Ugleholdt XR Zhu CF Deacon C Orskov DF Steiner JJ Holst 2004 Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1 Endocrinology 145 1349 1355 14630721 10.1210/en.2003-0801 1:CAS:528: DC%2BD2cXhs1Wit78%3D (Pubitemid 38281019)
33. DJ Drucker T Jin SL Asa TA Young PL Brubaker 1994 Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line Mol Endocrinol 8 1646 1655 7535893 10.1210/me.8.12.1646 1:CAS:528:DyaK2MXivFegsLg%3D
34. MB Toft-Nielsen MB Damholt S Madsbad, et al. 2001 Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients J Clin Endocrinol Metab 86 3717 3723 11502801 10.1210/jc.86.8.3717 1:CAS:528:DC%2BD3MXlvFektLc%3D (Pubitemid 32755966)
35. MM Swarbrick KL Stanhope IT Austrheim-Smith, et al. 2008 Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery Diabetologia 51 1901 1911 18704364 10.1007/s00125-008-1118-5 1:CAS:528:DC%2BD1cXhtVOnurvK
36. J Korner M Bessler W Inabnet C Taveras JJ Holst 2007 Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding Surg Obes Relat Dis 3 597 601 17936091 10.1016/j.soard.2007.08. 004 (Pubitemid 350091417)
37. D Pacheco DA de Luis A Romero, et al. 2007 The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats Am J Surg 194 221 224 17618808 10.1016/j.amjsurg.2006.11.015 1:CAS:528:DC%2BD2sXnsFWmtbY%3D (Pubitemid 47008973)
38. S Klein B Mittendorfer JC Eagon, et al. 2006 Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease Gastroenterology 130 1564 1572 16697719 10.1053/j.gastro.2006.01. 042 1:CAS:528:DC%2BD28Xls1Wisbs%3D (Pubitemid 43668832)
39. B Laferrere J Teixeira J McGinty, et al. 2008 Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes J Clin Endocrinol Metab 93 2479 2485 18430778 10.1210/jc.2007-2851 1:CAS:528:DC%2BD1cXoslyktb8%3D (Pubitemid 352008510)
40. JJ Meier B Gallwitz N Siepmann, et al. 2003 Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia Diabetologia 46 798 801 12764578 10.1007/s00125-003-1103-y 1:CAS:528:DC%2BD3sXkvFyjtrk%3D (Pubitemid 36831408)
41. JJ Meier MA Nauck A Pott, et al. 2006 Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans Gastroenterology 130 44 54 16401467 10.1053/j.gastro.2005. 10.004 1:CAS:528:DC%2BD28XhtFCgtbw%3D (Pubitemid 43049834)
42. LL Baggio DJ Drucker 2007 Biology of incretins: GLP-1 and GIP Gastroenterology 132 2131 2157 17498508 10.1053/j.gastro.2007.03.054 1:CAS:528:DC%2BD2sXmsVynsrY%3D (Pubitemid 46711096)
43. JJ Meier B Gallwitz N Siepmann, et al. 2003 Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia Diabetologia 46 798 801 12764578 10.1007/s00125-003-1103-y 1:CAS:528:DC%2BD3sXkvFyjtrk%3D (Pubitemid 36831408)
44. MA Nauck MM Heimesaat C Orskov JJ Holst R Ebert W Creutzfeldt 1993 Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus J Clin Invest 91 301 307 8423228 10.1172/JCI116186 1:STN:280: DyaK3s7jvFaguw%3D%3D
45. F Rubino M Gagner P Gentileschi, et al. 2004 The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism Ann Surg 240 236 242 15273546 10.1097/01.sla.0000133117. 12646.48 (Pubitemid 38963013)
46. C Guidone M Manco E Valera-Mora, et al. 2006 Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery Diabetes 55 2025 2031 16804072 10.2337/db06-0068 1:CAS:528:DC%2BD28XmvVChtL4%3D (Pubitemid 44509976)
47. R Jorde PG Burhol JA Johnson 1981 The effect of jejunoileal bypass on postprandial release of plasma gastric inhibitory polypeptide (GIP) Scand J Gastroenterol 16 313 319 7031848 1:STN:280:DyaL38%2FosVaitw%3D%3D
48. KR Sirinek TM O'Dorisio D Hill AS McFee 1986 Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass Surgery 100 781 787 3532392 1:STN:280:DyaL2s%2FhvFCiuw%3D%3D
49. M Bose B Olivan J Teixeira FX Pi-Sunyer B Laferrere 2009 Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg 19 217 229 18820978 10.1007/s11695-008-9696-3
50. N Irwin PR Flatt 2009 Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications Diabetologia 10.1007/s00125-009-1422-8 19533083